Malik Asim, El Masry Karim Medhat, Ravi Mini, Sayed Falak
Emerg Infect Dis. 2016 Mar;22(3):515-7. doi: 10.3201/eid2203.151049.
As of June 19, 2015, the World Health Organization had received 1,338 notifications of laboratory-confirmed infection with Middle East respiratory syndrome coronavirus (MERS-CoV). Little is known about the course of or treatment for MERS-CoV in pregnant women. We report a fatal case of MERS-CoV in a pregnant woman administered combination ribavirin-peginterferon-α therapy.
截至2015年6月19日,世界卫生组织已收到1338例中东呼吸综合征冠状病毒(MERS-CoV)实验室确诊感染的通报。关于孕妇感染MERS-CoV的病程或治疗方法,人们知之甚少。我们报告了一例接受利巴韦林-聚乙二醇干扰素-α联合治疗的孕妇感染MERS-CoV的死亡病例。